Literature DB >> 20004430

Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.

Jabbar Saliba1, Nader R Kasim, Robyn A Tamboli, James M Isbell, Pam Marks, Irene D Feurer, Alp Ikizler, Naji N Abumrad.   

Abstract

BACKGROUND: Obesity and type 2 diabetes are associated with renal dysfunction, which improves after Roux-en-Y gastric bypass (RYGB). During a 12-month follow-up period, we studied prospectively the changes in glomerular and tubular functions that occurred in excessively obese diabetic and non diabetic subjects after RYGB.
METHODS: The cohort included 35 patients, 54% of whom had type 2 diabetes. Glomerular filtration rate (GFR) was estimated using creatinine clearance. Tubular function was studied by measuring the ratio of urinary cystatin C to urinary creatinine (UCC ratio).
RESULTS: Baseline renal parameters, anthropometric characteristics, and changes in body mass index after the surgical procedures were similar between the 2 cohorts. At 12 months after RYGB, creatinine clearance decreased 15% in diabetics (P = .02) and 21% in nondiabetics (P = .03). A change in GFR was seen earlier in the nondiabetics (-29% after 6 months; P = .003). The UCC ratio was increased at both 6- and 12-month follow-ups (P = .03 and .003, respectively) only in the diabetic group.
CONCLUSION: GFR was improved at 12 months after RYGB, with nondiabetics showing a greater propensity score. Tubular function remained unchanged in the nondiabetic subjects, but worsening occurred in the diabetic subjects. These results underscore the importance of reversal of excessive obesity before the onset of frank diabetes. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004430      PMCID: PMC2813906          DOI: 10.1016/j.surg.2009.09.017

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  34 in total

1.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

2.  Health-related quality of life, quality-adjusted life years, and quality-adjusted life expectancy in new york city from 1995 to 2006.

Authors:  Erica I Lubetkin; Haomiao Jia
Journal:  J Urban Health       Date:  2009-03-13       Impact factor: 3.671

3.  Evaluation of renal biopsy samples of patients with diabetic nephropathy.

Authors:  D Suzuki; H Takano; M Toyoda; T Umezono; G Uehara; T Sakai; S Y Zhang; Y Mori; M Yagame; M Endoh; H Sakai
Journal:  Intern Med       Date:  2001-11       Impact factor: 1.271

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

5.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

6.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.

Authors:  M Praga; E Hernández; J C Herrero; E Morales; Y Revilla; R Díaz-González; J L Rodicio
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Etiology of type II diabetes mellitus: role of the foregut.

Authors:  W J Pories; R J Albrecht
Journal:  World J Surg       Date:  2001-04-18       Impact factor: 3.352

8.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

9.  Lifestyle factors, obesity and the risk of chronic kidney disease.

Authors:  Bénédicte Stengel; Michelle E Tarver-Carr; Neil R Powe; Mark S Eberhardt; Frederick L Brancati
Journal:  Epidemiology       Date:  2003-07       Impact factor: 4.822

10.  Measurement of cystatin-C and creatinine in urine.

Authors:  Kazuo Uchida; Akiko Gotoh
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

View more
  21 in total

Review 1.  Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

2.  Changes in renal function following Roux-en-Y gastric bypass: a prospective study.

Authors:  Jorge L Zelada Getty; Isam N Hamdallah; Hazem N Shamseddeen; Jennifer Wu; Roger K Low; Jacqueline Craig; Mohamed R Ali
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

Review 3.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

Review 4.  Bariatric surgery and renal function.

Authors:  Andrew Currie; Andrew Chetwood; Ahmed R Ahmed
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

5.  Renal glomerular and tubular injury after gastric bypass in obese rats.

Authors:  Benjamin K Canales; Leticia Reyes; Mary K Reinhard; Saeed R Khan; Carolina G Goncalves; Michael M Meguid
Journal:  Nutrition       Date:  2011-07-01       Impact factor: 4.008

6.  Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels.

Authors:  Annabel Chen-Tournoux; Abigail May Khan; Aaron L Baggish; Victor M Castro; Marc J Semigran; Elizabeth L McCabe; George Moukarbel; Jason Reingold; Sofia Durrani; Gregory D Lewis; Christopher Newton-Cheh; Marielle Scherrer-Crosbie; Lee M Kaplan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2010-11-15       Impact factor: 2.778

7.  Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Hongyan Huang; Jun Lu; Xiaojiang Dai; Zhixin Li; Liyong Zhu; Shaihong Zhu; Liangping Wu
Journal:  Obes Surg       Date:  2021-08-06       Impact factor: 4.129

8.  Sleeve Gastrectomy Compared with Gastric Bypass for Morbidly Obese Patients with End Stage Renal Disease: a Decision Analysis.

Authors:  Rashikh A Choudhury; Gerard Hoeltzel; Kas Prins; Eric Chow; Hunter B Moore; Peter J Lawson; Dor Yoeli; Akshay Pratap; Peter L Abt; Kristoffel R Dumon; Kendra D Conzen; Trevor L Nydam
Journal:  J Gastrointest Surg       Date:  2019-05-01       Impact factor: 3.452

9.  The Short-Term Renal Effects of Bariatric Surgery: A Comparative Study Between Sleeve Gastrectomy and One Anastomosis Gastric Bypass Operations Among Egyptian Patients With Severe Obesity.

Authors:  Amir I Bassiony; Alaa Sabry; Osama Shiha; Ahmed ElGeidie; Mohammed K Nassar
Journal:  Obes Surg       Date:  2020-07-23       Impact factor: 4.129

Review 10.  Obesity-related cardiorenal disease: the benefits of bariatric surgery.

Authors:  Wiebke Fenske; Thanos Athanasiou; Leanne Harling; Christiane Drechsler; Ara Darzi; Hutan Ashrafian
Journal:  Nat Rev Nephrol       Date:  2013-08-06       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.